Search Results - "Kölsch, H"

Refine Results
  1. 1

    Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume by Striepens, N, Scheef, L, Wind, A, Meiberth, D, Popp, J, Spottke, A, Kölsch, H, Wagner, M, Jessen, F

    Published in Psychological medicine (01-09-2011)
    “…The apolipoprotein E4 allele (ApoE4) is an established genetic risk factor for Alzheimer's disease (AD). However, its effects on cognitive performance and…”
    Get more information
    Journal Article
  2. 2

    The plant sterol brassicasterol as additional CSF biomarker in Alzheimer's disease by Vanmierlo, T., Popp, J., Kölsch, H., Friedrichs, S., Jessen, F., Stoffel-Wagner, B., Bertsch, T., Hartmann, T., Maier, W., von Bergmann, K., Steinbusch, H., Mulder, M., Lütjohann, D.

    Published in Acta psychiatrica Scandinavica (01-09-2011)
    “…Vanmierlo T, Popp J, Kölsch H, Friedrichs S, Jessen F, Stoffel‐Wagner B, Bertsch T, Hartmann T, Maier W, von Bergmann K, Steinbusch H, Mulder M, Lütjohann D…”
    Get full text
    Journal Article
  3. 3

    Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients by Kölsch, H., Heun, R., Kerksiek, A., Bergmann, K.v., Maier, W., Lütjohann, D.

    Published in Neuroscience letters (30-09-2004)
    “…Alterations in brain cholesterol metabolism and reduced 24S-hydroxycholesterol plasma levels have been described in Alzheimer’s disease (AD) and vascular…”
    Get full text
    Journal Article
  4. 4

    A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI by Jessen, F, Gür, O, Block, W, Ende, G, Frölich, L, Hammen, T, Wiltfang, J, Kucinski, T, Jahn, H, Heun, R, Maier, W, Kölsch, H, Kornhuber, J, Träber, F

    Published in Neurology (19-05-2009)
    “…The need for biological markers of Alzheimer disease (AD) is constantly increasing. Proton magnetic resonance spectroscopy ((1)H-MRS) studies have provided…”
    Get full text
    Journal Article
  5. 5

    Effects of estrogen on brain development and neuroprotection—implications for negative symptoms in schizophrenia by Rao, M.L., Kölsch, H.

    Published in Psychoneuroendocrinology (01-04-2003)
    “…Increasing evidence during the last few years suggests that there are gender-specific differences in schizophrenia, influencing the age of onset, treatment…”
    Get full text
    Journal Article
  6. 6

    Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke by KÖLSCH, H, LINNEBANK, M, VON BERGMANN, K, MAIER, W, HEUN, R, LÜTJOHANN, D, JESSEN, F, WÜLLNER, U, HARBRECHT, U, THELEN, K. M, KREIS, M, HENTSCHEL, F, SCHULZ, A

    Published in Neurology (28-12-2004)
    “…Glutathione S-transferase omega-1 (GSTO1) protects from oxidative stress, a risk factor for Alzheimer disease (AD), vascular dementia (VaD), and stroke…”
    Get full text
    Journal Article
  7. 7

    ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia by Kölsch, H., Jessen, F., Freymann, N., Kreis, M., Hentschel, F., Maier, W., Heun, R.

    Published in Neuroscience letters (22-03-2005)
    “…Different studies have investigated the effect of the angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism on the risk of Alzheimer…”
    Get full text
    Journal Article
  8. 8

    Risk factors and early signs of Alzheimer's disease in a family study sample. Risk of AD by Heun, Reinhard, Kölsch, Heike, Jessen, Frank

    “…Several predictors of Alzheimer's disease (AD) have been identified. However, the relevance and independent contribution of risk factors and of possible early…”
    Get full text
    Journal Article
  9. 9

    Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease by KÖLSCH, H, LÜTJOHANN, D, LUDWIG, M, SCHULTE, A, PTOK, U, JESSEN, F, VON BERGMANN, K, RAO, M. L, MAIER, W, HEUN, R

    Published in Molecular psychiatry (01-01-2002)
    “…Cholesterol and 24S-hydroxycholesterol are involved in the pathogenesis of Alzheimer's disease (AD). Increased serum cholesterol concentrations have been…”
    Get full text
    Journal Article
  10. 10

    The variant methylenetetrahydrofolate reductase c.1298A > C (p.E429A) is associated with multiple sclerosis in a German case-control study by Klotz, L., Farkas, M., Bain, N., Keskitalo, S., Semmler, A., Ineichen, B., Jelcic, J., Klockgether, T., Kölsch, H., Weller, M., Linnebank, M.

    Published in Neuroscience letters (14-01-2010)
    “…Multiple sclerosis (MS) is an inflammatory demyelinating autoimmune disease of the central nervous system. We investigated the association of two missense…”
    Get full text
    Journal Article
  11. 11

    Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17β by KÖLSCH, H, LUDWIG, M, LÜTJOHANN, D, RAO, M. L

    Published in Journal of Neural Transmission (02-04-2001)
    “…24-Hydroxycholesterol, the main cholesterol elimination product of the brain is increased in serum of Alzheimer patients. This oxysterol behaves neurotoxic…”
    Get full text
    Journal Article
  12. 12

    The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma by LINNEBANK, M, SCHMIDT, S, PELS, H, KÖLSCH, H, LINNEBANK, A, HEUN, R, SCHMIDT-WOLF, I. G. H, GLASMACHER, A, FLIESSBACH, K, KLOCKGETHER, T, SCHLEGEL, U

    Published in British journal of cancer (17-05-2004)
    “…Primary central nervous system lymphomas (PCNSL) frequently reveal genomic instability. We analysed different functional genetic variants affecting the folate…”
    Get full text
    Journal Article
  13. 13

    Gene variations in GSTM3 are a risk factor for Alzheimer's disease by Hong, G.-S, Heun, R, Jessen, F, Popp, J, Hentschel, F, Kelemen, P, Schulz, A, Maier, W, Kölsch, H

    Published in Neurobiology of aging (01-05-2009)
    “…Abstract Oxidative stress is a relevant pathomechanism in Alzheimer's disease (AD) and gene variations in the glutathione S-transferase M3 gene (GSTM3),…”
    Get full text
    Journal Article
  14. 14

    Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients by Sauder, S, Kölsch, H, Lütjohann, D, Schulz, A, von Bergmann, K, Maier, W, Heun, R

    Published in Journal of Neural Transmission (01-10-2005)
    “…The peroxisome proliferator-activated receptor gamma (PPARgamma) is a nuclear hormone receptor, that is involved in lipid and glucose metabolism, which both…”
    Get full text
    Journal Article
  15. 15

    Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile by Feuchtl, A, Bagli, M, Stephan, R, Frahnert, C, Kölsch, H, Kühn, K U, Rao, M L

    Published in Pharmacopsychiatry (01-07-2004)
    “…Serotonin plays an important role in psychiatric diseases, most notably in depression and anxiety. Seven different major serotonin receptor subtypes have been…”
    Get more information
    Journal Article
  16. 16

    Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions by Qureischie, H., Heun, R., Popp, J., Jessen, F., Maier, W., Schmitz, S., Hentschel, F., Kelemen, P., Kölsch, H.

    Published in Journal of Neural Transmission (01-04-2009)
    “…Cholesteryl ester transfer protein (CETP), a component of the high density lipoprotein (HDL), plays a central role in reverse cholesterol transport. We…”
    Get full text
    Journal Article
  17. 17

    Polymorphism in the peroxisome proliferator-activated receptor α gene influences the risk for Alzheimer's disease by BRUNE, S, KÖLSCH, H, PTOK, U, MAJORES, M, SCHULZ, A, SCHLOSSER, R, RAO, M. L, MAIER, W, HEUN, R

    Published in Journal of Neural Transmission (01-09-2003)
    “…The peroxisome proliferator-activated receptor alpha (PPAR-alpha) is a member of the steroid hormone super family of ligand-inducible transcription factors,…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Common genetic variants of homocysteine metabolism in ischemic stroke: a case-control study by Linnebank, M., Montenarh, M., Kölsch, H., Linnebank, A., Schnez, K., Schweichel, D., Pohl, C., Urbach, H., Heun, R., Harbrecht, U., Klockgether, T., Wüllner, U.

    Published in European journal of neurology (01-08-2005)
    “…Hyperhomocysteinemia is a risk factor for ischemic stroke. We investigated five functional polymorphisms involved in homocysteine metabolism in each 159 stroke…”
    Get full text
    Journal Article